NCT06431399View on ClinicalTrials.gov

To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 23, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

July 12, 2024

Conditions
Healthy
Interventions
DRUG

JLP-2004 qd

Group I(Peroid I-JLP-2004 FAST, Peroid II-JLP-2004 FED), Group II(Period I-JLP-2004 FED, Period II-JLP-2004 FAST)

Trial Locations (1)

28644

RECRUITING

Chungbuk National University Hospital, Chungju

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY

NCT06431399 - To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004 | Biotech Hunter | Biotech Hunter